Jim Simons Shattuck Labs, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 250,600 shares of STTK stock, worth $278,166. This represents 0.0% of its overall portfolio holdings.

Number of Shares

250,600

Previous 392,010 36.07%

Holding current value

$278,166

Previous $1.51 Million 42.23%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$3.0 - $4.85 $424,230 - $685,838	-141,410 Reduced 36.07%	250,600 $874,000
Q2 2024 Aug 09, 2024	BUY	$3.56 - $11.18 $633,359 - $1.99 Million	177,910 Added 83.1%	392,010 $1.51 Million
Q1 2024 May 13, 2024	BUY	$7.37 - $10.09 $154,033 - $210,881	20,900 Added 10.82%	214,100 $1.91 Million
Q4 2023 Feb 13, 2024	SELL	$1.37 - $7.24 $8,768 - $46,336	-6,400 Reduced 3.21%	193,200 $1.38 Million
Q3 2023 Nov 14, 2023	SELL	$1.42 - $3.16 $40,044 - $89,112	-28,200 Reduced 12.38%	199,600 $303,000
Q2 2023 Aug 11, 2023	SELL	$2.52 - $3.66 $51,324 - $74,543	-20,367 Reduced 8.21%	227,800 $711,000
Q1 2023 May 12, 2023	SELL	$2.5 - $4.72 $20,332 - $38,387	-8,133 Reduced 3.17%	248,167 $730,000
Q4 2022 Feb 13, 2023	SELL	$1.96 - $3.26 $17,248 - $28,687	-8,800 Reduced 3.32%	256,300 $589,000
Q3 2022 Nov 14, 2022	SELL	$2.6 - $5.52 $107,640 - $228,527	-41,400 Reduced 13.51%	265,100 $716,000
Q2 2022 Aug 12, 2022	BUY	$2.7 - $4.59 $36,450 - $61,965	13,500 Added 4.61%	306,500 $1.24 Million
Q1 2022 May 13, 2022	SELL	$4.22 - $8.89 $12,238 - $25,781	-2,900 Reduced 0.98%	293,000 $1.25 Million
Q4 2021 Feb 11, 2022	BUY	$8.36 - $21.08 $2.47 Million - $6.24 Million	295,900 New	295,900 $2.52 Million

Others Institutions Holding STTK

# of Institutions

Shares Held

28.8M

Call Options Held

300

Put Options Held

1.2K

View Full List

About Shattuck Labs, Inc.

Ticker STTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,382,000
Market Cap $47M
Description
Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...

More about STTK

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account